Cathie Wood's ARK ETF published their daily trades for Wednesday, November 13th, 2024, revealing a series of strategic buys and sells across various sectors. The most significant investment of the day was in CRISPR Therapeutics AG (NASDAQ:CRSP), with ARK purchasing 185,429 shares valued at approximately $9.4 million. This move underscores ARK's continued confidence in the gene-editing company, building on previous acquisitions earlier in the week.
Another notable buy was Aurora Innovation Inc (NASDAQ:AUR), where ARK acquired 217,190 shares, amounting to over $1.1 million. This purchase aligns with ARK's focus on innovative technologies, particularly in the autonomous vehicle space.
ARK also demonstrated interest in the e-commerce giant Amazon.com Inc (NASDAQ:AMZN), buying 4,469 shares with a total value close to $933,618. This trade follows a significant investment in Amazon last Thursday, suggesting a bullish stance on the online retailer's growth prospects.
In the semiconductor arena, ARK added 1,000 shares of Advanced Micro Devices Inc (NASDAQ:AMD) to its ARKX (NYSE:ARKX) ETF, reflecting a belief in the company's potential despite the smaller scale of the transaction ($143,630).
Furthermore, ARK showed an appetite for aerospace, with purchases in Archer Aviation Inc (NYSE:NYSE:ACHR) and Blade Air Mobility Inc (NASDAQ:BLDE), totaling $267,460 and $162,539 respectively. These trades indicate ARK's anticipation of growth within the urban air mobility sector.
On the sell side, ARK divested 149,84 shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT) from its ARKG ETF, valued at $88,855. This follows a pattern of selling Adaptive Biotechnologies shares over the past week, suggesting a strategic reduction in this holding.
The largest sale of the day was Unity Software Inc (NYSE:NYSE:U), with ARK selling 566,369 shares, resulting in a significant cash-out of approximately $10.9 million. This continues a trend of ARK reducing its position in Unity Software (ETR:SOWGn), as seen in previous days' trades.
Other sales included Exact Sciences Corp (NASDAQ:EXAS) and Rocket Lab USA Inc (NASDAQ:RKLB), with ARK parting with shares worth around $2 million and $7 million respectively.
In summary, Cathie Wood's ARK ETF's daily trades indicate a strategic rebalancing, with a clear focus on companies at the forefront of technological innovation and a gradual move away from certain biotech and software stocks. As ARK continues to adjust its portfolio, investors are provided with insights into where the firm sees the most promising opportunities for growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.